Erratum: Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model ((Brain (2015) DOI: 10.1093/brain/awu355);Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model

Brain

Volumn 138, Issue 2, 2015, Pages 336-355

  Martins, Carla ^a   Hulkova, Helena ^b   Dridi, Larbi ^a   Dormoy Raclet, Virginie ^a   Grigoryeva, Lubov ^a   Choi, Yoo ^a   Langford Smith, Alexander ^c   Wilkinson, Fiona L ^c   Ohmi, Kazuhiro ^d   DiCristo, Graziella ^a   Hamel, Edith ^e   Ausseil, Jerǒme ^f   Cheillan, David ^g   Moreau, Alain ^a   Svobodova, Eva ^b   Hàjkovà, Zuzana ^h   Tesařovà, Markéta ^h   Hansíkovà, Hana ^h   Bigger, Brian W ^c   Hrebícek, Martin ^b   Pshezhetsky, Alexey V ^a   more..

^a UNIVERSITY OF MONTREAL   (Canada)

^b Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acetyl CoA: glucosaminide N acetyltransferase; Glycosaminoglycans; Heparan sulphate; Knockout mouse model; Mucopolysaccharidosis

Indexed keywords

ACETYL COENZYME A; ACYLTRANSFERASE; ALPHA GALACTOSIDASE; ALPHA N ACETYLGLUCOSAMINIDASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; GANGLIOSIDE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; GLUCOSAMINE ACETYLTRANSFERASE; MAP1LC3 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTOPHAGY; BEHAVIOR CHANGE; BRAIN METABOLISM; BRAIN NERVE CELL; BRAIN TISSUE; CELL ULTRASTRUCTURE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINE RELEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIUM; ENERGY METABOLISM; FEMALE; FIBROBLAST; GENE; GENE INACTIVATION; GERM LINE; HGSNAT GENE; HYPERACTIVITY; KUPFFER CELL; LEARNING DISORDER; LIFESPAN; LIVER CELL; LONGEVITY; LYSOSOME; MALE; MEMORY DISORDER; MICROGLIA; MITOCHONDRIAL RESPIRATION; MOUSE; MOUSE MODEL; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; SANFILIPPO SYNDROME; SOMATOSENSORY CORTEX; URINE RETENTION; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; COMPLICATION; DEFICIENCY; GENETICS; METABOLISM; MITOCHONDRIAL DISEASES; NEURITIS; NEURODEGENERATIVE DISEASES; NEUROLOGIC EXAMINATION; PATHOLOGY; PHYSIOLOGY; PROTEOSTASIS DEFICIENCY; PSYCHOLOGY;

ACETYLTRANSFERASES; ANIMALS; BEHAVIOR, ANIMAL; ENERGY METABOLISM; GANGLIOSIDES; GLYCOSAMINOGLYCANS; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL DISEASES; MUCOPOLYSACCHARIDOSIS III; NEURITIS; NEURODEGENERATIVE DISEASES; NEUROLOGIC EXAMINATION; PROTEOSTASIS DEFICIENCIES;

EID: 84922373734     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv035     Document Type: Erratum

References (61)

1. Aronovich EL, Carmichael KP, Morizono H, Koutlas IG, Deanching M, Hoganson G, et al. Canine heparan sulfate sulfamidase and the molecular pathology underlying Sanfilippo syndrome type A in Dachshunds. Genomics 2000; 68: 80-4.
2. Aronovich EL, Johnston JM, Wang P, Giger U, Whitley CB. Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B. Genomics 2001; 74: 299-305.
3. Ausseil J, Desmaris N, Bigou S, Attali R, Corbineau S, Vitry S, et al. Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLoS One 2008; 3: e2296.
4. Baregamian N, Song J, Bailey CE, Papaconstantinou J, Evers BM, Chung DH, et al. Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis. Oxid Med Cell Longev 2009; 2: 297-306.
5. Bartsocas C, Grö be H, van de Kamp JJ, von Figura K, Kresse H, Klein U, et al. Sanfilippo type C disease: clinical findings in four patients with a new variant of mucopolysaccharidosis III. Eur J Pediatr 1979; 130: 251-8.
6. Bhaumik M, Muller VJ, Rozaklis T, Johnson L, Dobrenis K, Bhattacharyya R, et al. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology 1999; 9: 1389-96.
7. Bifsha P, Landry K, Ashmarina L, Durand S, Seyrantepe V, Trudel S, et al. Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway. Cell Death Differ 2007; 14: 511-23.
8. Bruyere J, Roy E, Ausseil J, Lemonnier T, Teyre G, Boh D, et al. Heparan sulphate saccharides modify focal adhesions: implication in mucopolysaccharidosis neuropathophysiology. J Mol Biol 2014; S0022-2836(14)00511-7. 50022-2836
9. Chatham JC, Marchase RB. Protein O-GlcNAcylation: a critical regulator of the cellular response to stress. Curr Signal Transduct Ther 2010; 5: 49-59.
10. Chen XH, Zhao YP, Xue M, Ji CB, Gao CL, Zhu JG, et al. TNFalpha induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol Cell Endocrinol 2010; 328: 63-9.
11. Chuang YC, Su WH, Lei HY, Lin YS, Liu HS, Chang CP, et al. Macrophage migration inhibitory factor induces autophagy via reactive oxygen species generation. PLoS One 2012; 7: e37613.
12. Crawley AC, Gliddon BL, Auclair D, Brodie SL, Hirte C, King BM, et al. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Res 2006; 1104: 1-17.
13. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992; 119: 961-75.
14. de Pablo-Latorre R, Saide A, Polishhuck EV, Nusco E, Fraldi A, Ballabio A. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum Mol Genet 2012; 21: 1770-81.
15. de Ruijter J, Maas M, Janssen A, Wijburg FA. High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study. Mol Genet Metab 2013; 109: 49-53.
16. DiRosario J, Divers E, Wang C, Etter J, Charrier A, Jukkola P, et al. Innate and adaptive immune activation in the brain of MPS IIIB mouse model. J Neurosci Res 2009; 87: 978-90.
17. Dudkova Z, Cederblad G, Hultman E. Determination of pyruvate dehydrogenase complex activity in muscle tissue. Klin. Biochem. Metab 1995; 3: 178-82.
18. Durand S, Feldhammer M, Bonneil E, Thibault P, Pshezhetsky AV. Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC. J Biol Chem 2010; 285: 31233-42.
19. Ellinwood NM, Wang P, Skeen T, Sharp NJ, Cesta M, Decker S, et al. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs. J Inherit Metab Dis 2003; 26: 489-504.
20. Feldhammer M, Durand S, Pshezhetsky AV. Protein misfolding as an underlying molecular defect in mucopolysaccharidosis III type C. PLoS One 2009; 4: e7434.
21. Ginsberg SD, Galvin JE, Lee VM, Rorke LB, Dickson DW, Wolfe JH, et al. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. J Neuropathol Exp Neurol 1999; 58: 815-24.
22. Hamano K, Hayashi M, Shioda K, Fukatsu R, Mizutani S. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathol 2008; 115: 547-59.
23. Hansen GM, Markesich DC, Burnett MB, Zhu Q, Dionne KM, Richter LJ, et al. Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. Genome Res 2008; 18: 1670-9.
24. Hocquemiller M, Vitry S, Bigou S, Bruyere J, Ausseil J, Heard JM. GAP43 overexpression and enhanced neurite outgrowth in mucopolysaccharidosis type IIIB cortical neuron cultures. J Neurosci Res 2010; 88: 202-13.
25. Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 1997; 6: 1879-85.
26. Klein U, Kresse H, von Figura K. Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts. Proc Natl Acad Sci USA 1978; 75: 5185-9.
27. Kyrklund T. Two procedures to remove polar contaminants from a crude brain lipid extract by using prepacked reversed-phase columns. Lipids 1987; 22: 274-7.
28. Langford-Smith A, Langford-Smith K, Jones SA, Wynn RF, Wraith JE, Wilkinson FL, et al. Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test. PLoS One 2011; 6: e25717.
29. Lema PP, Girard C, Vachon P. Evaluation of dexamethasone for the treatment of intracerebral hemorrhage using a collagenase-induced intracerebral hematoma model in rats. J Vet Pharmacol Ther 2004; 27: 321-8.
30. Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S, et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 1999; 96: 14505-10.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
32. Macauley SL, Sidman RL, Schuchman EH, Taksir T, Stewart GR. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration. Exp Neurol 2008; 214: 181-92.
33. Makinen MW, Lee CP. Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria. Arch Biochem Biophys 1968; 126: 75-82.
34. McGlynn R, Dobrenis K, Walkley SU. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 2004; 480: 415-26.
35. Mohammed EE, Snella EM, Rutz-Mendicino MM, Echevarria FD, Awedikian R, Whitley EM, et al. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice. Mol Genet Metab 2012; 107: 129-35.
36. Mosca F, Fattorini D, Bompadre S, Littarru GP. Assay of coenzyme Q(10) in plasma by a single dilution step. Anal Biochem 2002; 305: 49-54.
37. Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, et al. Chimeric anti-ganglioside GM2 antibody with antitumor activity. Cancer Res 1994; 54: 1511-6.
38. Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 2001. p. 3421-52.
39. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 2003; 100: 1902-7.
40. Ohmi K, Kudo LC, Ryazantsev S, Zhao HZ, Karsten SL, Neufeld EF. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci USA 2009; 106: 8332-7.
41. Ohmi K, Zhao HZ, Neufeld EF. Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. PLoS One 2011; 6: e27461.
42. Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, et al. Mitochondria and quality control defects in a mouse model of Gaucher disease-links to Parkinson's disease. Cell Metab 2013; 17: 941-53.
43. Paxinos G, Franklin K. The mouse brain in stereotaxic coordinates. 4th ed. San Diego: Elsevier Academic Press; 2013.
44. Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 2004; 12: 87-92.
45. Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999; 105: 151-6.
46. Roy E, Bruyere J, Flamant P, Bigou S, Ausseil J, Vitry S, et al. GM130 gain-of-function induces cell pathology in a model of lysosomal storage disease. Hum Mol Genet 2012; 21: 1481-95.
47. Ruijter GJ, Valstar MJ, van de Kamp JM, van der Helm RM, Durand S, van Diggelen OP, et al. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol Genet Metab 2008; 93: 104-11.
48. Rustin P, hretien D, Bourgeron T, Gérard B, Rö tig A, Saudubray JM, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228: 35-51.
49. Ryazantsev S, Yu WH, Zhao HZ, Neufeld EF, Ohmi K. Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B. Mol Genet Metab 2007; 90: 393-401.
50. Sarna J, Miranda SR, Schuchman EH, Hawkes R. Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease. Eur J Neurosci 2001; 13: 1873-80.
51. Settembre C, Fraldi A, Medina DL, Ballabio A, et al. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 2013; 14: 283-96.
52. Seyrantepe V, Canuel M, Carpentier S, Landry K, Durand S, Liang F, et al. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage. Hum Mol Genet 2008; 17: 1556-68.
53. Seyrantepe V, Lema P, Caqueret A, Dridi L, Bel Hadj S, Carpentier S, et al. Mice doubly-deficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss. PLoS Genet 2010; 6: e1001118.
54. Srere PA. [1] Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]. In: John ML, editor. Methods in enzymology. Vol. 13. New York: Academic Press; 1969. p. 3-11.
55. Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 2008; 31: 240-52.
56. Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez Y, Reyero E, et al. Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 2007; 85: 612-22.
57. Vitner EB, Farfel-Becker T, Eilam R, Biton I, Futerman AH. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease. Brain 2012; 135: 1724-35.
58. Wada R, Tifft CJ, Proia RL. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 2000; 97: 10954-9.
59. Whitley CB, Ridnour MD, Draper KA, Dutton CM, Neglia JP. Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin Chem 1989; 35: 374-9.
60. Wilkinson FL, Holley RJ, Langford-Smith KJ, Badrinath S, Langford-Smith A, et al. Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS One 2012; 7: e35787.
61. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA 2003; 100: 14109-14